...
首页> 外文期刊>Experimental Biology and Medicine: Journal of the Society for Experimental Biology and Medicine >Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients
【24h】

Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients

机译:半乳糖血症患者外周血淋巴细胞中NADPH氧化酶活性受损

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Galactosemia is an autosomal recessive disorder with a wide range of clinical abnormalities. Cellular oxidative stress is considered as one of the pathogenic mechanisms of galactosemia. In this study, we examined the activity of NADPH oxidase (NOX), a major superoxide-generating enzyme system, in peripheral blood lymphocytes (PBL) from galactosemia patients. PBL were isolated from galactosemia patients and healthy control subjects and used for cell culture studies and biochemical assays. PBL were cultured in the presence or absence of galactose or galactose-1-phosphate (Gal-1-P), and enzyme activities and/or gene expression of NOX, catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPx) were measured in the cell homogenates. PBL isolated from galactosemia patients showed significantly reduced (P < 0.01) activities of catalase and GPx; however SOD activity remained unaltered. Galactosemia patients were found to have significantly (P < 0.01) increased levels of malondialdehyde (MDA) in blood lymphocytes. Enzymatic activity of NOX was significantly (P < 0.001) reduced in galactosemia patients; however, Western blotting revealed that NOX-1 protein was not significantly altered. Interestingly, levels of NOX activity in lymphocytes isolated from galactosemia patients significantly increased but remained subnormal when cultured in galactose-deficient medium for two weeks, indicating a galactose-mediated inhibition of NOX. Lymphocytes isolated from control subjects were found to have significantly (P < 0.01) reduced NOX activity when cultured in the presence of galactose or Gal-1-P for two weeks. These results show that galactose-induced cellular oxidative stress is not NOX mediated. However, impairment of the NOX system might be responsible for some of the clinical complications in galactosemia patients.
机译:半乳糖血症是一种常染色体隐性遗传疾病,具有多种临床异常情况。细胞氧化应激被认为是半乳糖血症的致病机制之一。在这项研究中,我们检查了半乳糖血症患者外周血淋巴细胞(PBL)中NADPH氧化酶(NOX)(一种主要的超氧化物生成酶系统)的活性。从半乳糖血症患者和健康对照组中分离出PBL,并将其用于细胞培养研究和生化分析。在存在或不存在半乳糖或半乳糖1-Gal-1-P(Gal-1-P)的情况下培养PBL,并测量NOX,过氧化氢酶,超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)的酶活性和/或基因表达在细胞匀浆。从半乳糖血症患者中分离出的PBL显示过氧化氢酶和GPx活性显着降低(P <0.01);但是,SOD的活性保持不变。半乳糖血症患者被发现血液中的丙二醛(MDA)含量显着(P <0.01)升高。半乳糖血症患者的NOX酶活性显着降低(P <0.001)。然而,蛋白质印迹显示NOX-1蛋白没有明显改变。有趣的是,从半乳糖血症患者分离的淋巴细胞中的NOX活性水平显着增加,但当在半乳糖缺乏的培养基中培养两周时仍保持低于正常水平,这表明半乳糖介导的NOX抑制作用。发现在半乳糖或Gal-1-P存在下培养两周后,从对照受试者中分离出的淋巴细胞的NOX活性显着降低(P <0.01)。这些结果表明,半乳糖诱导的细胞氧化应激不是NOX介导的。但是,NOX系统受损可能是半乳糖血症患者的某些临床并发症的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号